Get all the news you need in your inbox each morning. The medical service/device: The iLet Bionic Pancreas, an insulin pump. The service provider: CCS, a medical supplies distributor. The bill ...

There are 38 million Americans with diabetes, and 10% percent of those with diabetes have Type 1. Type 1 is usually diagnosed ...

The Irvine, California-based company makes an insulin pump called the iLet Bionic Pancreas, which was cleared by the Food and Drug Administration in 2023. Beta Bionics plans to use the proceeds to ...

Underwriters have a 30-day option to purchase extra 1.13 million shares from present owners at IPO price. Beta Bionics will ...

Beta Bionics today filed a prospectus outlining its aim to bring in $114.4 million in its initial public offering (IPO).

Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to ...

Irvine, California-based Beta Bionics, Inc. was founded to develop its iLet Bionic Pancreas ... in the early stages of development of an 'insulin pump that is designed to adhere directly to ...